Literature DB >> 7191777

Effects of second-generation platinum analogs on isolated PM-2 DNA and their cytotoxicity in vitro and in vivo.

S Mong, C H Huang, A W Prestayko, S T Crooke.   

Abstract

Using PM-2 DNA and cytotoxicity assay systems, we have studied several second-generation platinum analogs and compared these to the parent compound cis-diamminedichloroplatinum(II). These results indicate that all planar platinum(II) congeners induced similar effects upon interaction with PM-2 DNA, i.e., alteration of the tertiary DNA conformations. The reactivity of the analogs with DNA depended on the activity of the leaving groups. Octahedral platinum(IV) compounds, however, induced breakage of covalently closed circular PM-2 DNA, and the effects were not inhibited by either chloride or ethylenediaminetetraacetate. This suggests that breakage of isolated PM-2 DNA may be related to the axial trans bonds rather than the equatorial cis bonds of the solvated platinum(IV) compounds, since the activity of the dichloroplatinum(II) compounds has been shown to be inhibited by chloride ions. Studies on the in vitro and in vivo cytotoxicity of the platinum analogs demonstrated that the reactivity of analogs against PM-2 DNA correlated with in vitro and in vivo potencies. The reactivity with PM-2 DNA appeared to depend on the characteristics of the leaving group.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7191777

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  Synthetic methods for the preparation of platinum anticancer complexes.

Authors:  Justin J Wilson; Stephen J Lippard
Journal:  Chem Rev       Date:  2013-11-27       Impact factor: 60.622

Review 2.  A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.

Authors:  B J Foster; B J Harding; M K Wolpert-DeFilippes; L Y Rubinstein; K Clagett-Carr; B Leyland-Jones
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  High-performance liquid chromatographic procedures for the analysis of carboplatin in human plasma and urine.

Authors:  R C Gaver; G Deeb
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

4.  Effects of carboplatin on the testis. A histological study.

Authors:  P Köpf-Maier
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 5.  Advances in platinum cancer chemotherapy. Advances in the design of cisplatin analogues.

Authors:  P C Hydes; M J Russell
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

Review 6.  Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer.

Authors:  A J Wagstaff; A Ward; P Benfield; R C Heel
Journal:  Drugs       Date:  1989-02       Impact factor: 9.546

7.  Interaction of cis-diamminedichloroplatinum(II) with phi X174 DNA.

Authors:  A Zahoor; M V Lafleur; E J Pluijmackers-Westmijze; D I Edwards
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.